Canature Health released its 2026 interim report. In the first half, the company's operating revenue was 921 million yuan, up 3.6 percent year on year. Net profit attributable to the parent company was 40.41 million yuan, down 42.4 percent year on year. Net profit attributable to the parent company after deducting non-recurring items was 25.21 million yuan, down 62.7 percent year on year. Net operating cash flow was 157 million yuan, up 3.5 percent year on year. Earnings per share were 0.0661 yuan. In the second quarter, operating revenue was 504 million yuan, up 4.1 percent year on year, while net profit attributable to the parent company was 35.06 million yuan, down 22.7 percent year on year. As of the end of the second quarter, the company's total assets were 3.53 billion yuan, down 4.0 percent from the end of the previous year. Net assets attributable to the parent company were 1.267 billion yuan, up 0.5 percent from the end of the previous year. The company said its main business has not undergone any major changes, and its main products remain water treatment equipment such as whole-house water purifiers and whole-house water softeners. Management noted that increased exchange losses caused by the depreciation of the US dollar against the yuan, as well as higher investment losses from associated companies, affected performance.
Shanghai Canature EnvironmentalNet profit attributable to parent fell 42.4% YoY, with declines in adjusted profit and EPS.
